Nordson (NDSN) announces to acquire Atrion. This will enable it to strengthen its medical offerings and boost its position in the infusion and cardiovascular therapies market.
WESTLAKE, Ohio, May 28, 2024--Nordson Corporation (Nasdaq: NDSN) today announced that it has entered into a definitive agreement to acquire Atrion Corporation (Nasdaq: ATRI), a leader in proprietary medical infusion fluid delivery and niche cardiovascular solutions, for $460.00 per share in cash. This reflects a valuation of 15X Atrion’s 2024 full-year estimated EBITDA, inclusive of synergies Nordson expects to generate in the first two years of its ownership. The acquisition expands Nordson’s m
Insightful Analysis of Nordson Corp's Financial Health and Market Position